Zdrowie i gospodarka · 24/11/2014

FDA Issues Final Guidance for Human Drug Compounding Outsourcing Facilities Under Section 503B of the FD&C Act

The FDA has released a final guidance to help human drug compounders comply with new regulations, outlining the process for registering, re-registering, or de-registering outsourcing facilities with the agency